SCHEMBL22493867

SCHEMBL22493867

CC(C)(C)NCCc1cccnc1C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD38 P28907 1/20 0.38
ADRB2 P07550 1/20 0.34
ANO1 Q5XXA6 1/20 0.34
SSTR4 P31391 2/20 0.33
HDAC6 Q9UBN7 1/20 0.33
TP53BP1 Q12888 1/20 0.32
ADRB1 P08588 1/20 0.32
CTSL P07711 1/20 0.32
CTSB P07858 1/20 0.32
CTSS P25774 1/20 0.32
CTSK P43235 1/20 0.32
KCNH2 Q12809 1/20 0.32
P2RY1 P47900 1/20 0.31
PDE1A P54750 2/20 0.31
PDE1B Q01064 2/20 0.31
PDE1C Q14123 2/20 0.31
TAAR1 Q96RJ0 1/20 0.31
GAA P10253 1/20 0.31
MTNR1A P48039 1/20 0.31
TRPC5 Q9UL62 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22493402 0.79 P2RX7 (0.37) GRIN1GRIN2B
SCHEMBL12525192 0.78 GRM5 (0.42) CD38HDAC6PDE1APDE1BPDE1C
SCHEMBL22493346 0.76 ALDH1A1 (0.33) TP53BP1TAAR1MTNR1AKDM4EALDH1A1
SCHEMBL22493349 0.76 GRM5 (0.35) SSTR4P2RY1TAAR1MTNR1AKDM4E
SCHEMBL22493463 0.75 HTR2A (0.48) GAAMTNR1AGRIN1GRIN2B
SCHEMBL26853974 0.75 MAPK1 (0.34) MTNR1AKDM4EALDH1A1
SCHEMBL22864232 0.75 HDAC6 (0.46) HDAC6GAAKDM4EALDH1A1
SCHEMBL12818788 0.74 CD38 (0.41) CD38SSTR4HDAC6TAAR1TRPC5
SCHEMBL22864222 0.74 ALDH1A1 (0.34) ADRB2KCNH2KDM4EALDH1A1
SCHEMBL22493347 0.74 KCNN4 (0.44) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137506-A1 COMPOSITIONS AND METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS CURASEN THERAPEUTICS, INC. (US) 2024-06-27 WO disclosed
WO-2023225021-A1 COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) CURASEN THERAPEUTICS, INC. (US) 2023-11-23 WO disclosed
WO-2020198466-A9 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed
WO-2020198466-A1 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed